NCT04307849 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Achyut P, Bhatia N, Singh A, Verma R, Khandekar S, Pallav P, et al
Building support for gender equality among young adolescents in school: findings from Mumbai India. 2011.
Bhatla N, Achyut P, Ghosh S, Gautam A, Verma R
Safe Cities Free From Violence Against Women and Girls: Baseline Finding from the
Brault MA, Schensul SL, Bankar S
The role of pre-marital agency in delaying marriage and reproductive decision-making in urban India. In: Erausquin MWaJT, editor. Global Perspectives on Women's Reproductive and Sexual Health Across the Lifespan: Springer Press Publishers; 2017.
Cleland J, Ingham R, Stone N
Asking young people about sexual and reproductive behaviours: Illustrative Core Instruments. World Health Organization, 2001.
Hunsley J
Development of the treatment acceptability questionnaire. Journal of Psychopathology and Behavioral Assessment. 1992;14(1):55-64.
Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SL, Walters EE, Zaslavsky AM
Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002 Aug;32(6):959-76. doi: 10.1017/s0033291702006074.
Lewis CC, Fischer S, Weiner BJ, Stanick C, Kim M, Martinez RG
Outcomes for implementation science: an enhanced systematic review of instruments using evidence-based rating criteria. Implement Sci. 2015 Nov 4;10:155. doi: 10.1186/s13012-015-0342-x.
Wingood GM, DiClemente RJ
The ADAPT-ITT model: a novel method of adapting evidence-based HIV Interventions. J Acquir Immune Defic Syndr. 2008 Mar 1;47 Suppl 1:S40-6. doi: 10.1097/QAI.0b013e3181605df1.

Engaging Providers, Community Members, and Young Women to Adapt and Pilot a Youth-friendly Sexual and Reproductive Health Package in Low-income Communities in India

Details for clinical trial NCT04307849

Clinical trial NCT04307849 - References